Skip to main content

InnovAge Holding Corp. (INNV) Stock Forecast

Data as of May 10, 2026

Healthcare · Current price $7.63 (-5.52%)

Consensus Target
$6.80
Upside
-10.9%
Analysts
1
Rating
Sell(4.00)

Price Target Range

Low $5.00Consensus $6.80High $8.00
▲ Current $7.63

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Sell
Strong Buy0
Buy0
Hold0
Sell1
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

INNV vs Sector & Market

MetricINNVHealthcare AvgLarge Cap Avg
Analyst Rating4.002.232.41
Analyst Count1819
Target Upside-10.9%+1711.0%+16.4%
P/E Ratio-272.433.5527.60

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$232M$234M$237M2
2026-09-30$249M$252M$255M1
2026-12-31$252M$255M$258M1
2027-03-31$255M$257M$260M1
2027-06-30$258M$261M$264M1
2028-06-30$1.11B$1.11B$1.11B1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$0.04$0.06$0.072
2026-09-30$0.05$0.05$0.061
2026-12-31$0.09$0.09$0.091
2027-03-31$0.04$0.04$0.041
2027-06-30$0.05$0.05$0.051
2028-06-30$0.52$0.52$0.531

Frequently Asked Questions

What is the analyst consensus for INNV?

The consensus among 1 analysts covering InnovAge Holding Corp. (INNV) is Sell with an average price target of $6.80.

What is the highest price target for INNV?

The highest analyst price target for INNV is $8.00.

What is the lowest price target for INNV?

The lowest analyst price target for INNV is $5.00.

How many analysts cover INNV?

1 analysts have issued ratings for InnovAge Holding Corp. in the past 12 months.

Is INNV a buy or sell right now?

Based on 1 analyst ratings, INNV has a consensus rating of Sell (4.00/5) with a -10.9% upside to the consensus target of $6.80.

What are the earnings estimates for INNV?

Analysts estimate INNV will report EPS of $0.06 for the period ending 2026-06-30, with revenue estimated at $234M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.